1. Home
  2. IFN vs YDES Comparison

IFN vs YDES Comparison

Compare IFN & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo India Fund Inc. (The)

IFN

India Fund Inc. (The)

N/A

Current Price

$10.97

Market Cap

482.9M

Sector

Finance

ML Signal

N/A

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$3.20

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
IFN
YDES
Founded
N/A
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
482.9M
543.0M
IPO Year
1994
2024

Fundamental Metrics

Financial Performance
Metric
IFN
YDES
Price
$10.97
$3.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
138.0K
360.2K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.72
$1.70
52 Week High
$15.47
$22.00

Technical Indicators

Market Signals
Indicator
IFN
YDES
Relative Strength Index (RSI) 27.01 49.65
Support Level $10.84 $2.99
Resistance Level $11.79 $5.15
Average True Range (ATR) 0.13 0.75
MACD -0.06 -0.08
Stochastic Oscillator 11.49 31.46

Price Performance

Historical Comparison
IFN
YDES

About IFN India Fund Inc. (The)

India Fund Inc is a non-diversified closed-end management investment company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing in the equity securities of Indian companies. The company's portfolio is a non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities, and others.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: